Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Sandhoff

Showing results (221-230 of 256) with videos related to

Pageof 26
Sort By:
Human Genetics|November 1, 1986
The influence of low arylsulfatase A activity on neuropsychiatric morbidity: a large-scale screening in patientsP Propping, W Friedl, M Huschka, et al.
FEBS Letters|September 9, 1996
Only sphingolipid activator protein B (SAP-B or saposin B) stimulates the degradation of globotriaosylceramide by recombinant human lysosomal alpha-galactosidase in a detergent-free liposomal systemR Kase, U Bierfreund, A Klein, et al.
Cell Death and Differentiation|April 14, 1999
Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspasesB Brenner, K Ferlinz, H Grassmé, et al.
Biochimica Et Biophysica Acta|January 28, 1985
Soluble sphingomyelinase from human urine as antigen for obtaining anti-sphingomyelinase antibodiesG Weitz, M Driessen, E M Brouwer-Kelder, et al.
Pediatric Research|November 1, 1985
Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant)E Conzelmann, H Nehrkorn, H J Kytzia, et al.
The EMBO Journal|September 1, 1989
Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcriptsL E Quintern, E H Schuchman, O Levran, et al.
Neurochemical Research|February 11, 1999
Recombinant GM2-activator protein stimulates in vivo degradation of GA2 in GM2 gangliosidosis AB variant fibroblasts but exhibits no detectable binding of GA2 in an in vitro assayU Bierfreund, T Lemm, A Hoffmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1998
Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedureY Liu, K Suzuki, J D Reed, et al.
Biochemical and Biophysical Research Communications|August 23, 1996
Differential regulation of Src-family protein tyrosine kinases in GPI domains of T lymphocyte plasma membranesS Arni, S Ilangumaran, G van Echten-Deckert, et al.
Experimental Dermatology|December 19, 1998
Induction of apoptosis by synthetic ceramide analogues in the human keratinocyte cell line HaCaTM Bektas, Y Dullin, T Wieder, et al.
Pageof 26

Showing results (221-230 of 256) with videos related to

Sort By:
Pageof 26
Human Genetics|November 1, 1986
The influence of low arylsulfatase A activity on neuropsychiatric morbidity: a large-scale screening in patientsP Propping, W Friedl, M Huschka, et al.
FEBS Letters|September 9, 1996
Only sphingolipid activator protein B (SAP-B or saposin B) stimulates the degradation of globotriaosylceramide by recombinant human lysosomal alpha-galactosidase in a detergent-free liposomal systemR Kase, U Bierfreund, A Klein, et al.
Cell Death and Differentiation|April 14, 1999
Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspasesB Brenner, K Ferlinz, H Grassmé, et al.
Biochimica Et Biophysica Acta|January 28, 1985
Soluble sphingomyelinase from human urine as antigen for obtaining anti-sphingomyelinase antibodiesG Weitz, M Driessen, E M Brouwer-Kelder, et al.
Pediatric Research|November 1, 1985
Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant)E Conzelmann, H Nehrkorn, H J Kytzia, et al.
The EMBO Journal|September 1, 1989
Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcriptsL E Quintern, E H Schuchman, O Levran, et al.
Neurochemical Research|February 11, 1999
Recombinant GM2-activator protein stimulates in vivo degradation of GA2 in GM2 gangliosidosis AB variant fibroblasts but exhibits no detectable binding of GA2 in an in vitro assayU Bierfreund, T Lemm, A Hoffmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1998
Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedureY Liu, K Suzuki, J D Reed, et al.
Biochemical and Biophysical Research Communications|August 23, 1996
Differential regulation of Src-family protein tyrosine kinases in GPI domains of T lymphocyte plasma membranesS Arni, S Ilangumaran, G van Echten-Deckert, et al.
Experimental Dermatology|December 19, 1998
Induction of apoptosis by synthetic ceramide analogues in the human keratinocyte cell line HaCaTM Bektas, Y Dullin, T Wieder, et al.
Pageof 26